Another anti-IS drug, β-Caryophyllene, ameliorates cognitive impairment after IS through the cAMP/PKA/CREB/BDNF pathway in MCAO mice (Chen et al., 2020). The gene discussed is CREB1; the disease is Cognitive impairment.